SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 1 — James Madison

PatientJames Madison
Date of birth2003-03-16
IdentifiersMRN HR-EN007-SYN; SSN (made up) 000-07-2618
Document date2026-04-07
AuthorJosiah Pembroke-Achebe, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Subjective

The patient attends this visit for primary care visit for two years of recurrent sudden episodes of unresponsiveness, with low mood and anxiety, on levetiracetam started without a diagnosis. [S]

Objective

PHQ-9: 13; GAD-7: 14; AUDIT-C: 1; Hemoglobin: 14.9 g/dL; White blood cells: 6.4 10*3/uL; Platelets: 231 10*3/uL; Sodium: 139 mmol/L; Potassium: 4.2 mmol/L; Creatinine: 0.86 mg/dL; eGFR: 125 mL/min/1.73 m²; Glucose: 84 mg/dL; Calcium: 9.6 mg/dL; TSH: 1.8 mIU/L; QTc: 404 ms. [S]

Vital Signs

DateMeasureValueUnitProvenance
2026-04-07Body height168cmS
2026-04-07Body weight54kgS
2026-04-07Body mass index (BMI) [Ratio]19.1kg/m2S
2026-04-07Systolic blood pressure112mm[Hg]S
2026-04-07Diastolic blood pressure70mm[Hg]S
2026-04-07Heart rate76/minS
2026-04-07Respiratory rate14/minS
2026-04-07Body temperature36.7CelS
2026-04-07Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-04-07Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]13{score}S
2026-04-07Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]14{score}S
2026-04-07Total score [AUDIT-C]1{score}S
2026-04-07Hemoglobin [Mass/volume] in Blood14.9g/dL13.2-16.6 g/dLNormalS
2026-04-07Leukocytes [#/volume] in Blood by Automated count6.410*3/uL3.4-9.6 10*3/uLNormalS
2026-04-07Platelets [#/volume] in Blood by Automated count23110*3/uL150-400 10*3/uLNormalS
2026-04-07Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
2026-04-07Potassium [Moles/volume] in Serum or Plasma4.2mmol/L3.5-5.1 mmol/LNormalS
2026-04-07Creatinine [Mass/volume] in Serum or Plasma0.86mg/dL0.74-1.35 mg/dLNormalS
2026-04-07Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M125mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-04-07Glucose [Mass/volume] in Serum or Plasma84mg/dL70-99 mg/dLNormalS
2026-04-07Calcium [Mass/volume] in Serum or Plasma9.6mg/dL8.6-10.3 mg/dLNormalS
2026-04-07Thyrotropin [Units/volume] in Serum or Plasma1.8m[IU]/L0.4-4 mIU/LNormalS
2026-04-07Q-T interval corrected404msBelow 450 ms is normal for a manNormalS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Levetiracetam 500 mg oral tablet, one tablet twice daily, started at an emergency department visit four months before intake for possible seizures, without an EEGOne tablet twice dailyOral route2025-12-02 to 2026-04-30completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Problems

ProblemClinical statusVerificationCodeProvenance
Recurrent sudden episodes of unresponsiveness for two years, two or three a month: he 'blanks out', stops speaking, slumps or sinks to the floor with his eyes closed for two to ten minutes, and afterwards is tearful and tired, with no tongue biting, incontinence, or injury; first during a period of overwork and little sleep at college; with low mood and anxiety; unchanged on levetiracetam; under evaluation for epilepsy, functional (dissociative) seizures, syncope, and other causesactiveconfirmed R40.4S — Synthetic presenting problem echoing his documented overwork, infirm health, and low spirits, and the later accounts of sudden attacks; superseded by the diagnosis at the second visit.
Taking an antiseizure medicine (levetiracetam) started without a confirmed diagnosis of epilepsyactiveconfirmed Z79.899S — Synthetic medication problem for teaching about avoiding unneeded antiseizure medicines; resolved when the medicine was stopped.

Assessment

Plan of Treatment